Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|May 18, 2026
Induced pluripotent stem cells as platforms for engineering NK cell immunotherapiesAnna Jezierski, Jez Huang, Lea Desbiens, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2021
Development of a Blood-Brain Barrier Permeability Assay Using Human Induced Pluripotent Stem Cell Derived Brain Endothelial CellsClaudie Charlebois, Jez Huang, Caroline Sodja, et al.
Stem Cells (Dayton, Ohio)|August 25, 2023
Improved Cryopreservation of Human Induced Pluripotent Stem Cell (iPSC) and iPSC-derived Neurons Using Ice-Recrystallization InhibitorsSalma Alasmar, Jez Huang, Karishma Chopra, et al.
Fluids and Barriers of the CNS|May 26, 2023
Mouse embryonic stem cell-derived blood-brain barrier model: applicability to studying antibody triggered receptor mediated transcytosisAnna Jezierski, Jez Huang, Arsalan S Haqqani, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|April 6, 2013
The transcription factor Sry-related HMG box-4 (SOX4) is required for normal renal development in vivoJez Huang, Michel Arsenault, Martin Kann, et al.
Scientific Reports|February 1, 2018
A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosisMaria Ribecco-Lutkiewicz, Caroline Sodja, Julie Haukenfrers, et al.
Fluids and Barriers of the CNS|June 1, 2022
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapiesJez Huang, Ying Betty Li, Claudie Charlebois, et al.
Molecular Therapy. Oncology|April 10, 2024
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A Hay, et al.
Pageof 1